Clinical Trials Browser

Phase 1 × Recurrence × Introns × Clear all

NCT01622933 2017-08-31

Multiple Antigen-Engineered DC Vaccine for Melanoma

Phase 1 Completed

Melanoma, Neoplasm Metastasis, Recurrence

NCT00329368 2012-03-09

Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic Cancer

Phase 1 Completed

Neoplasms, Recurrence